CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health Care Benefits and ...
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...
CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from Market Perform to Outperform and raise its price target to $75 per share in a ...
BofA raised the firm’s price target on CVS Health (CVS) to $75 from $63 and keeps a Buy rating on the shares. Aetna can add $3-$4 per share of ...
CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...
CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...
CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...
CVS Health executives cited tech-enabled home care provider Signify Health and primary care entity Oak Street for helping to generate profit growth in the fourth quarter of 2024.
CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...
However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...
CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results